Publication | Open Access
Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway
59
Citations
42
References
2018
Year
Antioxidant CKI possess better clinical application against AML through the Prdxs/ROS/Trx1 signalling pathway.
| Year | Citations | |
|---|---|---|
Page 1
Page 1